ADIPOQ and atherosclerosis: This community-based cross-sectional study demonstrated that: 1) there were significant relationships between adiponectin and atherosclerosis in both genders; 2) these associations persisted after adjustment for conventional cardiovascular risk factors in both genders; and 3) adiponectin makes an additional contribution to predicting the risk of atherosclerosis, beyond the information provided by conventional cardiovascular risk factors.